CMN1 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Improved Profitability And MarginsImproved EBIT/EBITDA and net margins along with a 12.62% ROE indicate the company is extracting more profit from sales and capital. Sustained margin improvement supports internal funding for projects, enhances resilience to cost shocks, and underpins long‑term earnings quality.
Manageable Balance Sheet LeverageA 0.40 debt-to-equity and ~44% equity ratio point to conservative leverage and financial flexibility. This reduces refinancing risk, enables steady funding for multi‑year defense programs, and supports investment or working capital needs without immediate reliance on external capital.
Recurring Government Contracts And Aftermarket SalesBusiness model centers on multi‑year government contracts and installed‑base aftermarket demand (spares, maintenance, support). These recurring, mission‑critical revenue streams create predictable long‑term cash inflows and high customer stickiness versus one‑off commercial exposure.
Bears Say
Declining Revenue TrendA declining top line (-4.57%) reduces operational leverage and limits room to scale fixed costs. If sustained, slower revenue undermines reinvestment capacity, may compress long‑term growth, and forces greater reliance on margin improvements or cost control to sustain profits.
Severe Deterioration In Free Cash FlowA ~185% drop in free cash flow signals weakening cash generation despite reported earnings. Persistent FCF weakness raises funding risk for capex, working capital and dividends, potentially necessitating external financing or cutbacks that could impair long‑term competitiveness.
Revenue Exposed To Government Budget TimingHigh dependence on government procurement cycles makes revenues lumpy and sensitive to budget shifts and award timing. Structural exposure to public spending variability complicates forecasting, capacity planning and steady growth execution over multi‑year horizons.
Chemring News
CMN1 FAQ
What was Chemring’s price range in the past 12 months?
Currently, no data Available
What is Chemring’s market cap?
Chemring’s market cap is CHF1.77B.
When is Chemring’s upcoming earnings report date?
Chemring’s upcoming earnings report date is Dec 15, 2026 which is in 139 days.
How were Chemring’s earnings last quarter?
Chemring released its earnings results on Jun 02, 2026. The company reported CHF0.065 earnings per share for the quarter, the consensus estimate of CHF0.065 by CHF0.
Is Chemring overvalued?
According to Wall Street analysts Chemring’s price is currently Undervalued.
Does Chemring pay dividends?
Chemring does not currently pay dividends.
What is Chemring’s EPS estimate?
Chemring’s EPS estimate is 0.14.
How many shares outstanding does Chemring have?
Chemring has 272,126,800 shares outstanding.
What happened to Chemring’s price movement after its last earnings report?
Chemring reported an EPS of CHF0.065 in its last earnings report, expectations of CHF0.065. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Chemring?
Currently, no hedge funds are holding shares in CH:CMN1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chemring Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF6.86 (― Downside)
CHF6.86 (― Downside)
Insider Transactions
Bought Shares
Worth CHF267.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
47.50%
12-Months-Change
Fundamentals
Return on Equity
1.35%
Trailing 12-Months
Asset Growth
20.26%
Trailing 12-Months
Company Description
Chemring
Chemring Group Plc engages in the manufacture of technology products and services for the aerospace, defense, and security markets. It operates through the following segments: Sensors & Information; and Countermeasures & Energetics. The Sensors & Information segments provides consulting and technology services to solve security-critical issues. The Countermeasures & Energetics segment comprises of development and manufacture of expendable countermeasures for air and sea platforms, cartridge and propellant actuated devices, pyrotechnic devices for satellite launch and deployment, missile components, propellants, separation sub-systems, actuators, and energetic materials. The company was founded on November 30, 1905 and is headquartered in Romsey, the United Kingdom.
CMN1 Stock 12 Month Forecast
Average Price Target
CHF6.86